A real world study analysing pharmacokinetic of remdesivir in severe COVID-19 Pneumonia
Latest Information Update: 20 May 2021
At a glance
- Drugs Remdesivir (Primary)
- Indications COVID-19 pneumonia; SARS-CoV-2 acute respiratory disease
- Focus Expanded access; Pharmacokinetics
- 20 May 2021 New trial record
- 14 May 2021 Results published in the British Journal of Clinical Pharmacology